Thursday, January 26, 2023

US FDA exempts Glenmark#39;s Baddi plant due to drug shortage

US FDA exempts Glenmark#39;s Baddi plant due to drug shortage The exception given to Glenmark#39;s Baddi plant will be reconsidered if the market conditions change, the letter to the bourses stated.

from Moneycontrol Business News https://ift.tt/PK1tcFe

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...